Discovery Diabetes

Summary

The goal of this clinical trial is to learn if the Discovery Program can help improve diabetes management in adolescents and young adults with type 1 diabetes (T1D). The main questions it aims to answer are: Does the Discovery Program lead to better glycemic control as measured by HbA1c levels? How does participation in the Discovery Program affect diabetes distress and self-management skills? Researchers will compare participants in the Discovery Program to those receiving standard diabetes care to see if the program has a positive effect on diabetes management. Participants will: Engage in a 3-month intervention that includes personalized mobile health communications and clinician support. Complete surveys and assessments at the beginning of the study, and again at 3 and 6 months. Allow the study team to access their electronic health records for additional data on diabetes management.

Eligibility

Inclusion Criteria:

* Adolescents (13-17 years) and young adults (aged 18-21 years),
* Diagnosed with T1D for at least one year,
* Access to a smartphone,
* A My Health at Vanderbilt (MHAV) patient portal account,
* Ability to read, speak, and understand English,
* An appointment with an NP in the VUMC Eskind Clinic within 7 months of initial contact

Exclusion Criteria:

* Diagnosis of type 2 diabetes
* Any physical, cognitive, sensory or emotional condition precluding participation in the intervention (seeing/using a phone, hearing digital stories, answering questions).

Conditions2

Locations1 site

Browse More Trials